SEK 0.01
(4.55%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 5.03 Million SEK | -2.48% |
2022 | 5.16 Million SEK | -27.22% |
2021 | 7.09 Million SEK | -29.37% |
2020 | 10.04 Million SEK | 157.44% |
2019 | 3.9 Million SEK | -18.17% |
2018 | 4.76 Million SEK | 151.42% |
2017 | 1.89 Million SEK | -26.42% |
2016 | 2.57 Million SEK | 205.24% |
2015 | 844.59 Thousand SEK | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 762 Thousand SEK | 127.24% |
2024 Q2 | 2.78 Million SEK | 264.83% |
2023 Q1 | 679 Thousand SEK | 23.0% |
2023 FY | -15.23 Million SEK | -394.91% |
2023 Q3 | -3.52 Million SEK | -295.51% |
2023 Q4 | -2.79 Million SEK | 20.74% |
2023 Q2 | 1.8 Million SEK | 165.83% |
2022 Q2 | 2.45 Million SEK | 138.72% |
2022 Q1 | 1.02 Million SEK | -34.73% |
2022 FY | 5.16 Million SEK | -27.22% |
2022 Q4 | 552.04 Thousand SEK | -26.3% |
2022 Q3 | 749 Thousand SEK | -69.48% |
2021 FY | 7.09 Million SEK | -29.37% |
2021 Q1 | 2 Million SEK | 85.31% |
2021 Q3 | 897 Thousand SEK | -65.8% |
2021 Q4 | 1.57 Million SEK | 75.58% |
2021 Q2 | 2.62 Million SEK | 30.95% |
2020 FY | 10.04 Million SEK | 157.44% |
2020 Q3 | 747 Thousand SEK | -89.48% |
2020 Q4 | 1.08 Million SEK | 44.7% |
2020 Q2 | 7.1 Million SEK | 534.02% |
2020 Q1 | 1.12 Million SEK | -24.02% |
2019 Q2 | 570 Thousand SEK | 48.44% |
2019 Q1 | 384 Thousand SEK | -90.57% |
2019 FY | 3.9 Million SEK | -18.17% |
2019 Q4 | 1.47 Million SEK | 0.55% |
2019 Q3 | 1.46 Million SEK | 157.19% |
2018 Q2 | 255 Thousand SEK | 363.64% |
2018 FY | 4.76 Million SEK | 151.42% |
2018 Q4 | 4.07 Million SEK | 1037.56% |
2018 Q3 | 358 Thousand SEK | 40.39% |
2018 Q1 | 55 Thousand SEK | -93.55% |
2017 Q2 | 96 Thousand SEK | 0.0% |
2017 Q3 | 852.08 Thousand SEK | 787.59% |
2017 FY | 1.89 Million SEK | -26.42% |
2017 Q1 | 96 Thousand SEK | 0.0% |
2017 Q4 | 852.08 Thousand SEK | 0.0% |
2016 FY | 2.57 Million SEK | 205.24% |
2015 FY | 844.59 Thousand SEK | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
AddLife AB (publ) | 2.77 Billion SEK | 99.818% |
Biotage AB (publ) | 1.14 Billion SEK | 99.562% |
Bonesupport Holding AB (publ) | 533.12 Million SEK | 99.055% |
Doxa AB (publ) | 9.9 Million SEK | 49.121% |
Elekta AB (publ) | 6.77 Billion SEK | 99.926% |
iZafe Group AB (publ) | 293 Thousand SEK | -1619.113% |
Ortivus AB (publ) | 30.84 Million SEK | 83.668% |
Ortivus AB (publ) | 30.84 Million SEK | 83.668% |
Q-linea AB (publ) | 995 Thousand SEK | -406.231% |
Synsam AB (publ) | 617 Million SEK | 99.184% |